Hospitals in the Washington, D.C. area have voiced an urgent call to increase collections of blood supplies as they prepare for potential emergencies during the upcoming presidential inauguration weekend, reports WTOP.
Supply Chain
In a recent press release, HPS, a group purchasing organization (GPO) with more than 3,600 members, including 144 acute care and 1,466 non-acute care facilities, in 20 states, signed an agreement with Resource Optimization & Innovation (ROi), a provider-owned supply chain…
The U.S. Supreme Court on Friday agreed to review a dispute between Basel, Switzerland-based Novartis and Thousand Oaks, Calif.-based Amgen on whether drug companies must wait six months after winning regulatory approval before selling "copycat" versions of biologic drugs, reports…
HPS, a group purchasing organization based in Middleville, Mich., entered a strategic supply chain partnership with Resource Optimization & Innovation, a provider-owned supply chain services company in St. Louis.
Vermont Sen. Bernie Sanders (I) on Thursday criticized 13 Senate Democrats for voting against a measure he proposed to control drug costs, saying they lacked the "guts" to stand up to the drug industry, reports USA Today.
Advertisement
Fujifilm Medical Systems plans to remove four legacy duodenoscope models from clinical use "based on the limited number currently in use," according to a Food and Drug Administration safety alert issued Jan. 13.
Advanced Cooling Therapy (ACT) has been awarded a group purchasing agreement as a Breakthrough Technology for Patient Temperature Management Products and Accessories with Premier Inc., effective January 1, 2017.
Target Corp. recently backed Inspectorio, a technology startup focused on improving supply chain visibility and quality control, reports StarTribune.
Few people sign up and participate in clinical trials, and those who do don't always represent the entire U.S. population. Since a specific population can be more at risk for a certain disease, it's important this population is represented in…
Jim O'Neill, managing director at Silicon Valley investment company Mithril Capital Management, has been under consideration to head the Food and Drug Administration since early December. On Thursday, Balaji Srinivasan's name surfaced as a potential new candidate for the position,…